Article
Clinical Role of CYP2C19 Polymorphisms in Patients with Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency.
Acta chimica Slovenica - 1 Jan 2016
Grošelj Urh, Žerjav Tanšek Mojca, Trebušak Podkrajšek Katarina, Hovnik Tinka, Battelino Tadej, Vita Dolžan
Abstract excerpt
Extraadrenal enzymes such as CYP2C19 may participate in residual 21-hydroxylation of progesterone leading to milder phenotypes of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD). Among 94 21OHD patients 28 were homozygous or compound heterozygous for severe CYP21A2 mutations. We have reviewed their clinical phenotype and obtained information on maintenance doses of hydrocortisone and...
Topics
- Adolescent
- Adrenal Hyperplasia, Congenital
- Adult
- Child
- Child, Preschool
- Cytochrome P-450 CYP2C19
- Female
- Fludrocortisone
- Genotype
- Humans
- Hydrocortisone
